These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 29246130)

  • 21. Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial.
    Abounahia FF; Abu-Jarir R; Abounahia MF; Al-Badriyeh D; Abushanab D; Abu-Ghalwa M; Mansour A; Kurdi B; Al-Rifai H
    Clin Drug Investig; 2019 Nov; 39(11):1093-1107. PubMed ID: 31414269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial.
    Rysavy MA; Li L; Tyson JE; Jensen EA; Das A; Ambalavanan N; Laughon MM; Greenberg RG; Patel RM; Pedroza C; Bell EF;
    J Pediatr; 2021 Sep; 236():78-85.e5. PubMed ID: 34004189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
    Kirpalani H; Ratcliffe SJ; Keszler M; Davis PG; Foglia EE; Te Pas A; Fernando M; Chaudhary A; Localio R; van Kaam AH; Onland W; Owen LS; Schmölzer GM; Katheria A; Hummler H; Lista G; Abbasi S; Klotz D; Simma B; Nadkarni V; Poulain FR; Donn SM; Kim HS; Park WS; Cadet C; Kong JY; Smith A; Guillen U; Liley HG; Hopper AO; Tamura M;
    JAMA; 2019 Mar; 321(12):1165-1175. PubMed ID: 30912836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial.
    He Y; Zhang Y; Gao S; Wang X; He N; Zhang D; Dong W; Wieg C; Lei X
    Trials; 2020 Sep; 21(1):762. PubMed ID: 32883333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxygen saturation/FIO2 ratio at 36 weeks' PMA in 1005 preterm infants: Effect of gestational age and early respiratory disease patterns.
    Nobile S; Marchionni P; Gidiucci C; Correani A; Palazzi ML; Spagnoli C; Rondina C; ; Carnielli VP
    Pediatr Pulmonol; 2019 May; 54(5):637-643. PubMed ID: 30688034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia.
    Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B
    J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early vs delayed vitamin A supplementation in very-low-birth-weight infants.
    Robbins ST; Fletcher AB
    JPEN J Parenter Enteral Nutr; 1993; 17(3):220-5. PubMed ID: 8505826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysis.
    Marc I; Lavoie PM; McPhee AJ; Collins CT; Simonyan D; Pronovost E; Guillot M; Gould JF; Mohamed I; Beltempo M; Boutin A; Fortier I; Sullivan TR; Moore L; Makrides M
    BMJ Open; 2023 Jul; 13(7):e076223. PubMed ID: 37518076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiology and Predictors of Impaired Gas Exchange in Infants with Bronchopulmonary Dysplasia.
    Svedenkrans J; Stoecklin B; Jones JG; Doherty DA; Pillow JJ
    Am J Respir Crit Care Med; 2019 Aug; 200(4):471-480. PubMed ID: 30789787
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants.
    Werkman SH; Peeples JM; Cooke RJ; Tolley EA; Carlson SE
    Am J Clin Nutr; 1994 Mar; 59(3):586-92. PubMed ID: 8116534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.
    Chen X; Li H; Qiu X; Yang C; Walther FJ
    BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin A Supplementation for Prevention of Bronchopulmonary Dysplasia: Cornerstone of Care or Futile Therapy?
    Gawronski CA; Gawronski KM
    Ann Pharmacother; 2016 Aug; 50(8):680-4. PubMed ID: 27147702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very-low-birth-weight premature Thai infants: a randomized trial.
    Kiatchoosakun P; Jirapradittha J; Panthongviriyakul MC; Khampitak T; Yongvanit P; Boonsiri P
    J Med Assoc Thai; 2014 Oct; 97 Suppl 10():S82-8. PubMed ID: 25816542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of vitamin A supplementation in prevention of bronchopulmonary dysplasia in extremely low birth weight neonates: a systematic review of randomized trials.
    Garg BD; Bansal A; Kabra NS
    J Matern Fetal Neonatal Med; 2019 Aug; 32(15):2608-2615. PubMed ID: 29447482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Enteral Supplementation With High-Dose Docosahexaenoic Acid and Risk of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-analysis.
    Marc I; Boutin A; Pronovost E; Perez Herrera NM; Guillot M; Bergeron F; Moore L; Sullivan TR; Lavoie PM; Makrides M
    JAMA Netw Open; 2023 Mar; 6(3):e233934. PubMed ID: 36943265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.
    Gadhia MM; Cutter GR; Abman SH; Kinsella JP
    J Pediatr; 2014 Apr; 164(4):744-8. PubMed ID: 24388327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO; Anstead MI; Shook LA
    Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia.
    Pearson E; Bose C; Snidow T; Ransom L; Young T; Bose G; Stiles A
    J Pediatr; 1992 Sep; 121(3):420-7. PubMed ID: 1517921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High doses of enteral docosahexaenoic acid omega-3 supplementation for prevention of bronchopulmonary dysplasia in very preterm infants: a protocol for a systematic review and meta-analysis.
    Marc I; Boutin A; Pronovost E; Guillot M; Bergeron F; Moore L; Makrides M
    BMJ Open; 2022 Oct; 12(10):e064515. PubMed ID: 36253040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.